Cargando…
艾曲泊帕治疗成人慢性原发免疫性血小板减少症的疗效及安全性
OBJECTIVE: To investigate the safety and efficacy of eltrombopag for adult patients with chronic immune thrombocytopenia (cITP). METHODS: It was a randomised, single-centre, 6 weeks, placebo-controlled study. Beginning in January 29(th), 2013, 35 patients were enrolled, and the trial was completed o...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343115/ https://www.ncbi.nlm.nih.gov/pubmed/29551030 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.01.007 |